High-dose brachytherapy for prostate cancer that has returned
Part of Cancer, Injuries & trauma, Kidney & urinary clinical trials.
This trial tests a type of radiation therapy called high-dose-rate brachytherapy, which is given to men whose prostate cancer has come back after their first treatment. It aims to control the cancer while keeping side effects low.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are over 18 years old.
- You have prostate cancer that has come back, confirmed by a biopsy and advanced imaging.
- Your cancer is still hormone-sensitive (responding to hormone therapy).
- Your first treatment was either brachytherapy alone, external beam radiation, or external beam radiation plus a brachytherapy boost.
- The cancer has not spread to other parts of the body (no metastases).
- You are not resistant to hormone therapy (not castration-resistant).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a high-dose radiation treatment (brachytherapy) that places tiny radioactive seeds directly into the area where your prostate was. It is for men whose prostate cancer has returned only in that area after having their prostate removed.
This trial studies high-dose radiation (HDR) given after prostate cancer returns only in the prostate/seminal vesicles. It may help by trying to control the cancer when it has not spread elsewhere, using targeted treatment based on MRI and biopsy proof.
This study tests a focused (“salvage”) brachytherapy—radiation placed directly near the prostate—to treat prostate cancer that has returned after earlier radiation. It may help control the tumor while limiting radiation exposure to surrounding tissues, based on how well people fit the study’s safety and cancer details.
This trial tests a new way to use a type of internal radiation (high-dose-rate brachytherapy) guided by MRI to treat prostate cancer that has come back in the same area after previous radiation therapy. It is designed to be more precise and hopefully safer while using the latest PSMA PET scans to make sure the cancer hasn't spread.
This trial tests a second course of radiotherapy for men whose prostate cancer has come back in the prostate after an earlier course of radiotherapy. The goal is to check how well the body tolerates this retreatment, especially regarding side effects, and to see if it can help control the cancer.
This trial tests combining hormone therapy with different types of radiation (including high-dose external beam and brachytherapy) for men with prostate cancer that has a higher chance of coming back. It aims to see if adding radiation to the lymph nodes helps control the cancer better.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.